RTS Life Science Announces the Availability of New Sample Management Technical Paper
News May 14, 2008
RTS Life Science has announces the availability of its new Sample Management and Replication technical paper. The informative new poster is entitled, “A New Paradigm in Sample Library Management and Replication,” and discusses RTS’ innovative sample management solution Libradexx. The poster is now available free of charge in downloadable pdf format via www.rtslifescience.com or via e-mail on firstname.lastname@example.org.
Finding a solution which is suitable for all library sizes, manages the regeneration and replication process and incorporates the ability to report on results, while at the same time saving money, are just some of the challenges sample management and HTS professionals face when implementing a storage management system. This poster highlights RTS LibradexxTM, an integrated sample library management solution which allows plate management and data tracking to become ‘run of the mill’, freeing users to focus on the real challenges of sample management and HTS. RTS Libradexx supports both manual and automated storage solutions and is suitable for all library sizes.
The new technical poster was presented for the first time at SBS Annual Conference and Exhibition in April and is written by Chris Walsh, Julio Maher, Philip Cummings, David Harding and Claire Ridgway of RTS Life Science. This detailed poster discusses how RTS has partnered with a major pharmaceutical company to challenge the current accepted models for compound management and presents an overview of the outcome of this process. In particular, the poster details the increasing use of the Labcyte Echo 550/555 liquid handler by Sample Management and HTS professionals to perform very low liquid transfers.
With 25 years of experience delivering automation solutions, RTS Life Science is a major supplier of large scale sample storage and testing within the laboratory environment. Its market encompasses drug discovery applications within pharmaceutical and biotechnology companies, covering medical research, clinical trials and manufacturing applications.
Domainex Appoints Dr Bodo Spori as Head of Business Development for EuropeNews
Domainex Ltd, a privately-owned drug discovery services company, is pleased to announce the appointment of Dr Bodo Spori as Head of Business Development for Europe.READ MORE
New Drug Compounds Help Prevent Hearing LossNews
Researchers from St. Jude Children's Research Hospital have discovered that inhibiting an enzyme called cyclin-dependent kinase 2 (CDK2) protects mice and rats from noise- or drug-induced hearing loss. The study suggests that CDK2 inhibitors prevent the death of inner ear cells, which has the potential to save the hearing of millions of people around the world.READ MORE
Empowering Women in Technology Key to Boosting UK EconomyNews
A new report launched at London Stock Exchange for International Women’s Day, reveals the critical role women play in driving economic growth across the UK, with detailed research on 1,279 women-led companies showing a total contribution of £25.9 billion in revenue to the UK economy.READ MORE
Comments | 0 ADD COMMENT
6th Annual Congress on Biology and Medicine of Molecules
Sep 17 - Sep 18, 2018
World Congress on Pathology and Laboratory Medicine
Sep 10 - Sep 11, 2018
World Congress on Advances in Addiction Science and Medicine
Sep 24 - Sep 25, 2018
10th International Conference on Mass Spectrometry and Chromatography
Oct 08 - Oct 09, 2018